These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19124646)

  • 1. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
    Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
    Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
    Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP1 is required for adhesion molecule expression in atherogenesis.
    von Lukowicz T; Hassa PO; Lohmann C; Borén J; Braunersreuther V; Mach F; Odermatt B; Gersbach M; Camici GG; Stähli BE; Tanner FC; Hottiger MO; Lüscher TF; Matter CM
    Cardiovasc Res; 2008 Apr; 78(1):158-66. PubMed ID: 18093987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.
    Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X
    J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet.
    Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C
    Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benzoate plant metabolite ethyl gallate prevents cellular- and vascular-lipid accumulation in experimental models of atherosclerosis.
    Liu W; Liu J; Xing S; Pan X; Wei S; Zhou M; Li Z; Wang L; Bielicki JK
    Biochem Biophys Res Commun; 2021 Jun; 556():65-71. PubMed ID: 33839416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
    Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.
    Shrestha E; Hussein MA; Savas JN; Ouimet M; Barrett TJ; Leone S; Yates JR; Moore KJ; Fisher EA; Garabedian MJ
    J Biol Chem; 2016 May; 291(21):11172-84. PubMed ID: 27026705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
    Xu G; Watanabe T; Iso Y; Koba S; Sakai T; Nagashima M; Arita S; Hongo S; Ota H; Kobayashi Y; Miyazaki A; Hirano T
    Circ Res; 2009 Aug; 105(5):500-10. PubMed ID: 19644050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic Reticulum Stress Affects Lipid Metabolism in Atherosclerosis Via CHOP Activation and Over-Expression of miR-33.
    Sun Y; Zhang D; Liu X; Li X; Liu F; Yu Y; Jia S; Zhou Y; Zhao Y
    Cell Physiol Biochem; 2018; 48(5):1995-2010. PubMed ID: 30092598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
    Peng Y; Xu J; Zeng Y; Chen L; Xu XL
    Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy.
    Ma C; Zhang W; Yang X; Liu Y; Liu L; Feng K; Zhang X; Yang S; Sun L; Yu M; Yang J; Li X; Hu W; Miao RQ; Zhu Y; Li L; Han J; Chen Y; Duan Y
    Br J Pharmacol; 2018 May; 175(9):1486-1503. PubMed ID: 29394501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice.
    Hoekstra M; de Jong LM; van der Geest R; de Leeuw LR; Krisnamurthi R; Geerling JJ; Van Eck M
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
    Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M
    Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
    Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
    Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foam cells in atherosclerosis.
    Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
    Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.